VistaGen Therapeutics
Price & Volume
Stats
See more52W Range | $1.90-$4.88 |
Market Cap | $174.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $646,000 |
Revenue Growth (YoY) | 190.5% |
Gross Profit (12 Mos) | $646,000 |
Diluted EPS | -$1.92 |
News
See moreYahoo Finance • 6 days ago
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
Yahoo Finance • 3 months ago
VistaGen Therapeutics Inc Q1 Sales Increase
Yahoo Finance • 5 months ago
Vistagen appoints Elissa Cote as Chief Corporate Development Officer
Yahoo Finance • 5 months ago
Stifel reiterates buy rating on VistaGen stock amid clinical progress
About
CEO | Mr. Shawn K. Singh J.D. |
Address | 343 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 57 |
